Français Japonais Chinois Allemand Néerlandais Espagnol Portugais

    News

    Giroptic makes a splash with Facebook

    At Facebook’s annual conference in California, an enthusiastic Mark Zuckerberg gave a Giroptic iO camera to every attendee—and wrote a $1 million check to the Lille-based start-up.

    Arcelor Mittal Dunkerque investing in performance

    Steelmaker earmarks €31 million for continuous hot mill at Dunkerque plant.

    All news

    INNOVATIVE LILLE RESEARCH PROGRAM TARGETS DIABETES & OBESITY

    03 Feb 2016 | Front page, Health Nutrition, A region on the move

    Lille researcher Dr. François Pattou is charting new territory in the fight against diabetes and obesity, thanks to a ground-breaking sample collection.

    Lille University Hospital Center to fight diabetes

    Diabetes: 15 years of research at Lille hospital yields new insights

    Dr. François Pattou, head of general and endocrine surgery at Lille University Hospital Center (CHRU) and a researcher at France’s National Institute of Health and Medical Research (INSERM), has studied type 2 diabetes and obesity for 15 years. He has shown that bariatric surgery can improve and even treat type 2 diabetes, though the mechanism responsible for these benefits has yet to be identified.

    The only sample collection of its kind

    Tissue contributions, made before and after bariatric surgery by some 1,500 local patients with severe diabetes and/or obesity, have enabled Dr. Pattou to amass one of the world’s largest collections of samples for research into diabetes and obesity. For the first time, data taken directly from human subjects is being used to study these pathologies.

    Financial backing from Cœur et Artères

    All patients with obesity and type 2 diabetes will benefit from Dr. Pattou’s innovative approach. In December 2015, France’s Cœur et Artères Foundation awarded a three-year grant to his program, which the Foundation has classified as a programme d’excellence

    Source : http://www.nord-ouest.inserm.fr/

    Back to news